Coronavirus: Commission concludes exploratory talks with Valneva to secure a new potential vaccine

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


Today, the European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses.

Today’s finalisation of exploratory talks with Valneva come in addition to an already secured broad portfolio of vaccines to be produced in Europe, including the contracts already signed with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, and Moderna and exploratory talks concluded with Novavax. This diversified vaccines portfolio will ensure Europe is well prepared for vaccination, once the vaccines have been proven to be safe and effective, as is already the case for BioNTech/Pfizer and Moderna, recently authorised in the EU. Member States are able to donate vaccines to lower and middle-income countries or to re-direct it to other European countries.

President of the European Commission, Ursula von der Leyen, said: “The continuing COVID-19 pandemic in Europe and around the globe makes it more important than ever that all Member States have access to the broadest possible portfolio of vaccines to help protect people in Europe and beyond. Today’s step toward reaching an agreement with Valneva further complements the EU’s vaccines portfolio and demonstrates the Commission’s commitment to find a lasting solution to the pandemic.”

Stella Kyriakides, Commissioner for Health and Food Safety, said: “With this eighth vaccine, we are adding to our already broad and diversified range of vaccines in our portfolio. By doing this, we can maximise our chances of making sure that all citizens can have access to safe and effective of vaccinations by the end of 2021. All Member States have now started their vaccination campaigns and will start receiving an increasing number of doses in order to cover all their needs during this year.”

Valneva is a European biotechnology company developing an inactivated virus vaccine. This is a traditional vaccine technology, used for 60-70 years, with established methods and a high level of safety. Most of the influenza vaccines and many childhood vaccines use this technology. This is currently the only inactivated vaccine candidate in clinical trials against COVID-19 in Europe.

The Commission, with the support of EU Member States, has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the company’s experience in vaccine development and its production capacity to supply all EU Member States.

Background

The European Commission presented on 17 June a European strategy to accelerate the development, manufacturing and deployment of effective and safe vaccines against COVID-19. In return for the right to buy a specified number of vaccine doses in a given timeframe, the Commission finances part of the upfront costs faced by vaccines producers in the form of Advance Purchase Agreements. Funding provided is considered as a down-payment on the vaccines that will actually be purchased by Member States.

Since the high cost and high failure rate make investing in a COVID-19 vaccine a high-risk decision for vaccine developers, these agreements will therefore allow investments to be made that otherwise might not happen.

Once vaccines have been proven to be safe and effective and have been granted market authorisation by the European Medicines Agency, they need to be quickly distributed and deployed across Europe. On 15 October, the Commission set out the key steps that Member States need to take to be fully prepared, which includes the development of national vaccination strategies. The Commission is putting in place a common reporting framework and a platform to monitor the effectiveness of national vaccine strategies and has adopted further actions  to reinforce preparedness and response measures across the EU and a strategy on staying safe from COVID-19 during winter offering further support to Member States in the deployment of vaccines.

The Commission is also committed to ensuring that everyone who needs a vaccine gets it, anywhere in the world and not only at home. No one will be safe until everyone is safe. This is why it has raised almost €16 billion since 4 May 2020 under the Coronavirus Global Response, the global action for universal access to tests, treatments and vaccines against coronavirus and for the global recovery and has confirmed its interest to participate in the COVAX Facility for equitable access to affordable COVID-19 vaccines everywhere. As part of a Team Europe effort, the Commission announced is contributing with €400 million in guarantees an additional €100 million in grant funding to support COVAX Facility and its objectives in the context of the Coronavirus Global Response. This €500 million from the EU budget combined with contributions from EU Member States and the EIB will be a key contribution for the COVAX Facility to ensure over one billion vaccine doses will be made available to people in low- and middle-income countries by the end of 2021.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Scientists just got closer to making nuclear fusion work

This is how COVID-19 is affecting informal workers

‘Critical’ window of opportunity closing fast in Iraq, Security Council hears

Mental health at stake: A silent epidemic of 21st century

A Sting Exclusive: “The competitiveness of Europe depends on a digital single market”, EPP President Joseph Daul highlights live from European Business Summit 2015

Investing in working conditions and quality jobs

Service and Sacrifice: Guinean peacekeepers make their mark in Mali

“We need to accelerate our negotiation on the China-EU Investment Treaty”, Chinese Premier Li Keqiang highlights from the 21st EU-China summit in Brussels

What data dominance really means, and how countries can compete

Coronavirus has ‘pandemic potential’ – but what is a pandemic?

World must ‘step up’, match Pakistan’s compassion for refugees, says UN chief

Conquering COVID-19 through Collaboration

State aid: Commission invites comments on State aid rules for the deployment of broadband networks

‘This is a time for facts, not fear,’ says WHO chief as COVID-19 virus spreads

Powering through the pandemic

Multilateralism: The only path to address the world’s troubles, signals Guterres

Young people are Europe’s biggest value and hope

FROM THE FIELD: ‘Race is on’ to halt biodiversity loss in Indonesia

Why Eurozone urgently needs the ECB to print and distribute at least €500 billion

This US city put an algorithm in charge of its school bus routes and saved $5 million

India’s mega-rich are on the rise

‘Three-country crisis’ across central Sahel puts whole generation at risk, warns UN food agency

Comprehensive listening: a tool to humanize Primary Healthcare and medical specialties

4 radical shifts required to achieve universal health coverage worldwide

This is what the UK’s major supermarkets say about plastic packaging and the environment

Thursday’s Daily Brief: dire living conditions in Idlib, migrants at US southern border, end in sight for trachoma, Human Rights Council

In polarized America, a new divide looms

Austrian Presidency priorities discussed in committees

Aviation Safety: Commission adopts new EU Air Safety List

These are the OECD’s most productive economies

Prospect of lasting peace ‘fading by the day’ in Gaza and West Bank, senior UN envoy warns

What is a gender parity accelerator, and how does it work?

New Zealand Prime Minister opens door to 4-day working week

Waste-free consumption: 3 reasons why cities will lead

Recession: the best argument for growth

More ambition needed for EU recovery instruments, says majority of MEPs

Athens urged to fast track asylum seekers amid island shelters crisis – UNHCR

Drones, disinfectant, distancing – Europe’s beaches open up

Draghi proposes timeframe for full Banking Union in five years

Africa-Europe Alliance: Four new financial guarantees worth €216 million signed under the EU External Investment Plan

Over 330,000 Congolese migrants at risk after mass deportations from Angola – UN rights chief

Virtual Doctor: a core part of modern healthcare?

Innovating together: connectivity that matters

How to build a model for human security in the Fourth Industrial Revolution

Global economy to see ‘steady’ growth of three per cent in 2019 despite risks, says UN

ACP-EU : Agreement on climate change, migration and post-Cotonou

The Tears of lovely Memories

What the US and the world can expect from the 8 November election?

Mobile 360 Series – Russia & CIS: Empowering the Digital Economy

Why EU’s working and unemployed millions remain uncertain or even desperate about their future

Afghanistan: EU reinforces humanitarian support with €40 million as crisis worsens

EU leaders slammed on anti-tax evasion inaction and expensive energy

144 years on, Universal Postal Union meets to define its 21st Century role

EU and Overseas Countries and Territories boost cooperation at annual Forum with €44 million

Warmer months ahead for many parts of the planet: UN weather agency

EU Facility for Refugees in Turkey: €6 billion to support refugees and local communities in need fully mobilised

Service and Sacrifice: Ugandan ‘Blue Helmets’ support UN efforts to bring peace to Somalia

London wants to treat violent crime like a disease

UN chief welcomes South Sudan’s Unity government, lauds parties for ‘significant achievement’

EU Commission: The banks are not obliged to finance the real economy

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s